Compare Amgen, Inc. (AMGN) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Tripadvisor Inc Common Stock — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Tripadvisor Inc Common Stock trades at $11.04 (market cap $1.28B). The key difference: Amgen, Inc. is far larger — about 175.1× Tripadvisor Inc Common Stock's market cap, and Amgen, Inc. pays a 2.43% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| AMGN | TRIP | |
|---|---|---|
Market Cap | $224.14B | $1.28B |
Sector | Health | Consumer Cyclical |
52-Week High | $417.20 | $19.14 |
52-Week Low | $271.18 | $9.24 |
Enterprise Value | $267.45B | $1.33B |
Dividend Yield | 2.43% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
